SEC Form 4 · accession 0001179022-18-000072
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kary Eldred
Director
Period of report
Sep 25, 2018
Accepted (ET)
Sep 26, 2018 · 7:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2018 | P | 2,000 | $6.0999 | A | 41,382 | D | |
| Common StockF1 | holding | — | — | — | 2,425 | I | as UTMA custodian for minor child | |
| Common StockF2 | holding | — | — | — | 2,000 | I | held in trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F2These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.